New CII Stories: A call for practitioner experiences with the hydrocodone/apap rescheduling.

New CII Stories: A call for practitioner experiences with the hydrocodone/apap rescheduling.

Today the Drug Enforcement Administration (DEA) officially rescheduled hydrocodone combination products (HCP) from Schedule III to Schedule II.  HCP’s are...

All original content on these pages is fingerprinted and certified by Digiprove